What Has Been the Growth Trajectory for the Implantable Defibrillators Market in Recent Years?
The implantable defibrillators market has seen considerable growth due to a variety of factors.
•Over the last few years, there has been a stable increase in the market size for implantable defibrillators. The market value is projected to rise from $5.54 billion in 2024 to $5.73 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 3.4%.
The growth witnessed in the past years can be ascribed to factors such as the growing number of cardiac disorder cases, clinical research and evidence, a rise in elderly population, enhanced awareness and education, along with collaborations and partnerships.
How Does the Forecast Look for the Implantable Defibrillators Market?
The implantable defibrillators market is expected to maintain its strong growth trajectory in upcoming years.
• In the coming years, substantial growth is anticipated in the implantable defibrillators market. It is projected to rise to "$7.21 billion by 2029, given a compound annual growth rate (CAGR) of 5.9%.
This growth during the projected period can be linked to factors such as the integration of remote monitoring and telemedicine, widening of indications, emphasis on managing heart failure, adoption of personalized medicine strategies, and the worldwide expansion of healthcare infrastructure. Key trends during this forecast duration encompass miniaturization and novel designs, enhanced connectivity and remote monitoring, personalized therapy methods, leadless implantable defibrillators, and advancements in battery technology.
What Are The Leading Drivers Of Growth In The Implantable Defibrillators Market?
The surge in sudden cardiac arrest incidents is anticipated to fuel the expansion of the implantable defibrillators market. Sudden cardiac arrest (SCA) is when the heartbeat ceases without warning. Implantable defibrillators can provide critical treatment by identifying and rectifying irregular heart rhythms that may culminate in SCA. A study by the Journal of the American College of Cardiology, a medical journal based in the US, cites SCD as the cause for 185,000 to 450,000 deaths annually in the US, accounting for 7% to 18% of all deaths. As such, the rising frequency of sudden cardiac arrest is propelling the growth of the implantable defibrillators market.
How Are The Segments Defined Within The Global Implantable Defibrillators Market?
The implantable defibrillators market covered in this report is segmented –
1) By Product Type: Single Chambered Implantable Defibrillators, Dual Chambered Implantable Defibrillators, Biventricular Implantable Defibrillators
2) By Procedure Type: Trans-Venous Implantable Defibrillators, Subcutaneous Implantable Defibrillators
3) By End User: Hospitals And Clinics, Ambulatory Surgery Centers, Other End Users
Subsegments:
1) By Single Chambered Implantable Defibrillators: Standard Single Chamber ICDs, Leadless Single Chamber ICDs
2) By Dual Chambered Implantable Defibrillators: Standard Dual Chamber ICDs, Advanced Dual Chamber ICDs
3) By Biventricular Implantable Defibrillators: Standard Biventricular ICDs, Advanced Biventricular ICDs With CRT
Pre-Book The Implantable Defibrillators Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are New Trends Expected To Influence The Growth Of The Implantable Defibrillators Market?
In the implantable defibrillators market, the main trend garnering attention is product innovation. To maintain their market position, major companies in the market such as Medtronic are focusing on the development of new products. As an example, in December 2023, Medtronic, a medical device company based in Ireland, introduced a new kind of implantable cardioverter-defibrillator known as the Aurora extravascular ICD. Instead of being placed under the collarbone, this device is inserted under the skin under the left armpit. Although it mirrors the size, shape, and battery life of Medtronic's conventional transvenous ICDs, it offers the added advantage of providing defibrillation during cardiac arrest, as well as continual pacemaker therapies. The Epsila leads, linked to the heart beneath the breastbone via minimally invasive methods, further enhance the device. Additionally, the implant is equipped with Medtronic’s Smart Sense and SureScan technologies that respectively aim to reduce the chance of unnecessary shocks and allow patients to undergo MRI scans with the device in place.
Who Are the Key Players in the Implantable Defibrillators Market?
Major companies operating in the implantable defibrillators market include:
• Boston Scientific Corporation
• LivaNova PLC
• Biotronik SE & Co KG
• MicroPort Scientific Corporation
• Medtronic plc
• St. Jude Medical Inc.
• Abbott Laboratories
• Sorin Group Italia S.r.l.
• Nihon Kohden Corporation
• Koninklijke Philips N.V.
• Fukuda Denshi Co Ltd.
• Progetti S.r.l.
• Imricor Medical Systems Inc.
• ZOLL Medical Corporation
• Physio-Control International Inc.
• Cardiac Science Corporation
• Defibtech LLC
• HeartSine Technologies LLC
• Schiller AG
• CU Medical Systems Inc.
• Mindray Medical International Limited
• Shenzhen Mindray Bio-Medical Electronics Co Ltd.
• Beijing M&B Electronic Instruments Co Ltd.
• Bexen Cardio SL
• Pacemaker Technologies
• EBR Systems Inc.
What Is The Most Dominant Region In The Implantable Defibrillators Market?
North America was the largest region in the implantable defibrillators market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global implanted defibrillator market forecast period. The regions covered in the implantable defibrillators market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
